Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
American Society for Gastrointestinal Endoscopy
Study examines radiation dose estimates for pregnant women undergoing therapeutic ERCP
May 14th, 2009
Pregnant women with gallstone disease may require immediate endoscopic intervention because of potentially life-threatening cholangitis (infection in the bile ducts) or gallstone pancreatitis (inflammation of the pancreas). The radiation exposure in endoscopic retrograde cholangiopancreatography (ERCP), which is used to treat these conditions, is a concern because fetal tissues are more susceptible to radiation injury. Researchers from Greece found that the radiation risks associated with ERCP procedures are not trivial and that accurate fetal dose estimation is now available regardless of patient body size, operating parameters, equipment used and gestational stage. The study appears in...
Source: Women's Health Weekly (2009-05-14)
|
